Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 482

1.

Role of Toxoplasma IgA as Part of a Reference Panel for the Diagnosis of Acute Toxoplasmosis during Pregnancy.

Olariu TR, Blackburn BG, Press C, Talucod J, Remington JS, Montoya JG.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01357-18. doi: 10.1128/JCM.01357-18. Print 2019 Feb.

2.

Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis.

Olariu TR, Remington JS, Montoya JG.

Pediatr Infect Dis J. 2014 Jun;33(6):566-70. doi: 10.1097/INF.0000000000000256.

PMID:
24445828
3.

Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.

Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG.

Pediatr Infect Dis J. 2011 Dec;30(12):1056-61. doi: 10.1097/INF.0b013e3182343096.

PMID:
21956696
4.

Risk factors for Toxoplasma gondii infection in the United States.

Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG.

Clin Infect Dis. 2009 Sep 15;49(6):878-84. doi: 10.1086/605433.

PMID:
19663709
5.

Management of Toxoplasma gondii infection during pregnancy.

Montoya JG, Remington JS.

Clin Infect Dis. 2008 Aug 15;47(4):554-66. doi: 10.1086/590149. Review.

PMID:
18624630
6.

Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America.

Rosso F, Les JT, Agudelo A, Villalobos C, Chaves JA, Tunubala GA, Messa A, Remington JS, Montoya JG.

Am J Trop Med Hyg. 2008 Mar;78(3):504-8.

PMID:
18337350
7.

The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis.

Montoya JG, Berry A, Rosso F, Remington JS.

J Clin Microbiol. 2007 May;45(5):1463-8. Epub 2007 Feb 21.

8.

Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis.

Nowakowska D, Colón I, Remington JS, Grigg M, Golab E, Wilczynski J, Sibley LD.

J Clin Microbiol. 2006 Apr;44(4):1382-9.

9.

Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults.

Press C, Montoya JG, Remington JS.

J Clin Microbiol. 2005 Jul;43(7):3481-3.

10.

Management of community-acquired respiratory tract infections.

Remington JS.

Clin Infect Dis. 2004 Sep 1;39 Suppl 3:S141. No abstract available.

PMID:
15546108
11.

Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy.

Montoya JG, Huffman HB, Remington JS.

J Clin Microbiol. 2004 Oct;42(10):4627-31.

12.

Recent developments for diagnosis of toxoplasmosis.

Remington JS, Thulliez P, Montoya JG.

J Clin Microbiol. 2004 Mar;42(3):941-5. Review. No abstract available.

13.

TCR V beta 8+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.

Kang H, Liesenfeld O, Remington JS, Claflin J, Wang X, Suzuki Y.

J Immunol. 2003 Apr 15;170(8):4254-9.

14.

Inhibition of secretion of interleukin-1alpha and tumor necrosis factor alpha by the ketolide antibiotic telithromycin.

Araujo FG, Slifer TL, Remington JS.

Antimicrob Agents Chemother. 2002 Oct;46(10):3327-30.

15.

VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS.

J Clin Microbiol. 2002 Jul;40(7):2504-8.

16.

Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide.

Araujo FG, Slifer TL, Remington JS.

Clin Microbiol Infect. 2002 Jan;8(1):26-30.

17.

Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center.

Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, Giannetti N, Miller J, Remington JS.

Clin Infect Dis. 2001 Sep 1;33(5):629-40. Epub 2001 Aug 6. Review.

PMID:
11486285
19.

Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory.

Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS.

J Infect Dis. 2001 Apr 15;183(8):1248-53. Epub 2001 Mar 16.

PMID:
11262207
20.

Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers.

Liesenfeld O, Montoya JG, Tathineni NJ, Davis M, Brown BW Jr, Cobb KL, Parsonnet J, Remington JS.

Am J Obstet Gynecol. 2001 Jan;184(2):140-5.

PMID:
11174493
21.

Strain typing of Toxoplasma gondii: comparison of antigen-coding and housekeeping genes.

Lehmann T, Blackston CR, Parmley SF, Remington JS, Dubey JP.

J Parasitol. 2000 Oct;86(5):960-71.

PMID:
11128519
22.

Activity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondii.

Khan AA, Slifer TR, Araujo FG, Remington JS.

Antimicrob Agents Chemother. 2001 Jan;45(1):48-51.

23.

Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.

Beaman MH, Remington JS, Meyer DJ.

Immunol Cell Biol. 2000 Dec;78(6):608-15.

PMID:
11114971
24.

Detection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women.

Suzuki Y, Ramirez R, Press C, Li S, Parmley S, Thulliez P, Remington JS.

J Clin Microbiol. 2000 Nov;38(11):3967-70.

25.

Protection against lipopolysaccharide-induced death by fluoroquinolones.

Khan AA, Slifer TR, Araujo FG, Suzuki Y, Remington JS.

Antimicrob Agents Chemother. 2000 Nov;44(11):3169-73.

26.

Strategies for the successful treatment of gram-positive bacterial infections.

Remington JS.

Clin Infect Dis. 2000 Sep;31 Suppl 4:S150-1. No abstract available.

PMID:
11017865
27.

Introduction

Remington JS.

Clin Infect Dis. 2000 Sep;31 Suppl 4:S123. No abstract available.

PMID:
11017860
28.

Ketolide ABT-773 is active against Toxoplasma gondii.

Khan AA, Araujo FG, Craft JC, Remington JS.

J Antimicrob Chemother. 2000 Sep;46(3):489-92.

PMID:
10980181
29.

Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens.

Li S, Galvan G, Araujo FG, Suzuki Y, Remington JS, Parmley S.

Clin Diagn Lab Immunol. 2000 Sep;7(5):781-7.

30.

Effect of quinupristin/dalfopristin on production of cytokines by human monocytes.

Khan AA, Slifer TR, Araujo FG, Remington JS.

J Infect Dis. 2000 Jul;182(1):356-8. Epub 2000 Jun 30.

PMID:
10882624
32.

Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen.

Li S, Maine G, Suzuki Y, Araujo FG, Galvan G, Remington JS, Parmley S.

J Clin Microbiol. 2000 Jan;38(1):179-84.

33.

Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis.

Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS.

Ophthalmology. 1999 Aug;106(8):1554-63.

PMID:
10442904
34.

Quinupristin-dalfopristin is active against Toxoplasma gondii.

Khan AA, Slifer TR, Araujo FG, Remington JS.

Antimicrob Agents Chemother. 1999 Aug;43(8):2043-5.

35.

TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii.

Liesenfeld O, Kang H, Park D, Nguyen TA, Parkhe CV, Watanabe H, Abo T, Sher A, Remington JS, Suzuki Y.

Parasite Immunol. 1999 Jul;21(7):365-76.

36.

Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin.

Khan AA, Araujo FG, Brighty KE, Gootz TD, Remington JS.

Antimicrob Agents Chemother. 1999 Jul;43(7):1783-7.

37.

Effect of clarithromycin and azithromycin on production of cytokines by human monocytes.

Khan AA, Slifer TR, Araujo FG, Remington JS.

Int J Antimicrob Agents. 1999 Feb;11(2):121-32.

PMID:
10221415
38.

Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.

Khan AA, Lambert LH Jr, Remington JS, Araujo FG.

Antimicrob Agents Chemother. 1999 Apr;43(4):758-62.

40.

Use of ketolides in combination with other drugs to treat experimental toxoplasmosis.

Araujo FG, Khan AA, Bryskier A, Remington JS.

J Antimicrob Chemother. 1998 Nov;42(5):665-7.

PMID:
9848454
41.

Effect of trovafloxacin on production of cytokines by human monocytes.

Khan AA, Slifer TR, Remington JS.

Antimicrob Agents Chemother. 1998 Jul;42(7):1713-7.

42.

Fellowship training in infectious diseases: a report from the regional and national meetings of infectious diseases division chiefs and program directors.

Joiner KA, Powderly WG, Blaser MJ, Klempner MS, Locksley RM, Mandell GL, Preheim LC, Remington JS, Slama TG, Steigbigel NH, Bartlett JG.

Clin Infect Dis. 1998 May;26(5):1060-5.

PMID:
9597224
43.

Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: a case of mistaken identity.

Lopez FA, Crowley RS, Wastila L, Valantine HA, Remington JS.

J Heart Lung Transplant. 1998 Mar;17(3):321-4.

PMID:
9563611
44.

Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals.

Subauste CS, Fuh F, de Waal Malefyt R, Remington JS.

J Immunol. 1998 Apr 1;160(7):3403-11.

45.

Ocular toxoplasmosis after autologous peripheral-blood stem-cell transplantation.

Yadlapati S, Dorsky D, Remington JS, Edwards RL, Feingold JM, Tutschka PJ, Bilgrami S.

Clin Infect Dis. 1997 Nov;25(5):1255-6. No abstract available.

PMID:
9402400
46.
47.

Type I interferons enhance production of IFN-gamma by NK cells.

Hunter CA, Gabriel KE, Radzanowski T, Neyer LE, Remington JS.

Immunol Lett. 1997 Oct;59(1):1-5.

PMID:
9334850
48.

The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.

Araujo FG, Khan AA, Slifer TL, Bryskier A, Remington JS.

Antimicrob Agents Chemother. 1997 Oct;41(10):2137-40.

49.

Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice.

Suzuki Y, Rani S, Liesenfeld O, Kojima T, Lim S, Nguyen TA, Dalrymple SA, Murray R, Remington JS.

Infect Immun. 1997 Jun;65(6):2339-45.

50.

Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.

Khan AA, Slifer T, Araujo FG, Polzer RJ, Remington JS.

Antimicrob Agents Chemother. 1997 May;41(5):893-7.

Supplemental Content

Loading ...
Support Center